Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repressionJ. Protein&Cell.
Citation: Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repressionJ. Protein&Cell.

Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repression

  • Epigenetic editing enables programmable and heritable gene regulation without altering DNA sequence, yet existing platforms remain constrained by large size, cumbersome target design, and limited applicability. Here we engineered catalytically inactive ISDge10 and ISAam1 TnpB systems and developed highly compact RNA-guided epigenetic editors compatible with single AAV delivery for either transcriptional activation or repression. Activators based on these TnpBs (Dge10on and Aam1on) efficiently activated diverse endogenous genes <i>in vitro</i>, and AAV9-delivered Aam1on achieved robust <i>Pdx1</i> activation <i>in vivo</i>. For gene repression, by screening 248 human KRAB domains with verified effector activity, we identified the most potent effector domain for each TnpB system, resulting in the optimization of Dge10off and Aam1off. These epigenetic editors mediated durable transcriptional repression across multiple loci in diverse cell types. In a mouse model, single-AAV delivery of these editors efficiently suppressed <i>Vegfa</i> expression with no detectable activation of DNA damage response markers (γH2AX and p53), resulting in marked reductions in choroidal neovascularization area. Our study expands the epigenetic editing toolbox and provides a potentially safe and durable single-administration therapeutic strategy for wet age-related macular degeneration (wAMD).
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return